TrialSignal
Clinical trial intelligence report
Examining the Feasibility and Acceptability of a Novel App-based Cognitive Behavioral Therapy Intervention for Preventing Postpartum Depression
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06365645-Jul 28, 2026
NCT ID
NCT06365645
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Sponsor
Women and Infants Hospital of Rhode Island
Executive brief
Investment-Ready Snapshot
The M.Bapp study, sponsored by Women and Infants Hospital of Rhode Island, aims to assess the feasibility and acceptability of a novel app-based intervention designed to prevent postpartum depression (PPD) among high-risk mothers. Given that PPD affects 10-25% of mothers, particularly those with personal or obstetric risk factors, there is a significant market opportunity for effective digital health solutions in maternal mental health. The adaptation of the Mothers & Babies Program into an app format could enhance accessibility and engagement, potentially positioning M.Bapp as a leading digital intervention in this space. The study's outcomes may inform future commercialization strategies and partnerships, particularly in the context of increasing demand for digital health solutions in maternal care.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06365645
Indication
Postpartum Depression
Modality
behavioral intervention
Target
Cognitive Behavioral Therapy (CBT) intervention for postpartum depression prevention.
Intervention
M.Bapp, App-based parenting education
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.